Kazia Therapeutics (KZIA) Total Debt (2018 - 2025)
Kazia Therapeutics' (KZIA) quarterly Total Debt came in at $9.3 million in Q4 2025, up 369.17% YoY from $2.0 million in Q4 2024, and up 361.48% on a QoQ basis from $2.0 million in Q2 2025.
Kazia Therapeutics (KZIA) Total Debt (2018 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 5 years of Total Debt data on file, last reported at $9.3 million in Q4 2025.
- Quarterly Total Debt rose 369.17% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (up 369.17% YoY) and the FY2025 annual result came in at $2.0 million, down 52.74% from the prior year.
- Total Debt rose to $9.3 million in Q4 2025, from $2.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $9.3 million in Q4 2025 to a low of -$1.3 million in Q2 2022.
- A 4-year average of $3.5 million and a median of $3.1 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt surged 1442.76% — and 2024, when it sank 64.55%.
- Tracing KZIA's Total Debt over 4 years: stood at $362883.0 in 2022, then jumped by 1442.76% to $5.6 million in 2023, then slumped by 64.55% to $2.0 million in 2024, then jumped by 369.17% to $9.3 million in 2025.
- The last three Total Debt figures came in at $9.3 million (Q4 2025), $2.0 million (Q2 2025), and $2.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.31 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Jun 30, 2024 | 4.27 Mn |
| Dec 31, 2023 | 5.60 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Dec 31, 2022 | 362,883.00 |
| Jun 30, 2022 | -1.32 Mn |
| Jun 30, 2018 | 63,591.10 |